**Author details**

Zhang Haibo\* and Meng Xu Cardiac Surgery Department, Beijing Anzhen Hospital, Capital Medical University, Beijing, China

\*Address all correspondence to: zhanghb2318@163.com

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**97**

*Transcatheter Treatment of Aortic Stenosis and Regurgitation*

(TAVI): A 20-year odyssey. Archives

Bash A, et al. Percutaneous transcatheter

prosthesis for calcific aortic stenosis first human case description. Circulation.

of Cardiovascular Diseases.

[9] Cribier A, Eltchaninoff H,

implantation of an aortic valve

[10] Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation.

[11] Lichtenstein SV, Cheung A, Ye J, et al. Transapical transcatheter aortic valve implantation in humans: Initial clinical experience. Circulation.

[12] Walther T, Simon P, Dewey T, et al. Transapical minimally invasive

Multicenter experience. Circulation.

Zickmann B, et al. First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheterization and Cardiovascular Interventions.

[14] Vahanian A, Alfieri O, Andreotti F, et al. Guidelines on the management of valvular heart disease (version 2012) The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). European Heart Journal.

[15] Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation

aortic valve implantation:

[13] Grube E, Laborde JC,

2002;**106**(24):3006-3008

2006;**113**:842-850

2006;**114**:591-596

2007;**116**:I240-I245

2005;**66**:465-469

2013;**66**(2):E1-E42

2012;**105**(3):146-152

*DOI: http://dx.doi.org/10.5772/intechopen.92997*

[1] Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with

Cardiovascular Health Study. Journal of the American College of Cardiology.

[2] Otto CM, Lind BK, Kitzman DW, et al. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. The New England Journal of Medicine.

[3] Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: A population-based study. Lancet.

[4] NHLBI Balloon Valvuloplasty Registry Participants. Percutaneous balloon aortic valvuloplasty. Acute and 30-day follow-up results in 674 patients from the NHLBI Balloon Valvuloplasty Registry. Circulation. 1991;**84**:2383-2397

[5] O'Neill WW. Predictors of longterm survival after percutaneous aortic valvuloplasty: Report of the Mansfield Scientific Balloon Aortic Valvuloplasty Registry. Journal of the American College of Cardiology. 1991;**17**:193-198

[6] Andersen HR, Knudsen LL, Hasenkam JM. Transluminal

Journal. 1992;**13**(5):704-708

[8] Cribier A. Development of

2000;**102**:813-816

implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. European Heart

[7] Bonhoeffer P, Boudjemline Y, Saliba Z, et al. Transcatheter implantation of a bovine valve in pulmonary position: A lamb study. Circulation.

transcatheter aortic valve implantation

calcific aortic valve disease:

**References**

1997;**29**:630-634

1999;**341**:142-147

2006;**368**:1005-1011

*Transcatheter Treatment of Aortic Stenosis and Regurgitation DOI: http://dx.doi.org/10.5772/intechopen.92997*
